ATE315399T1 - Hemmung von systemischen infektionen in menschen und wirbeltieren mit ballaststoffen - Google Patents

Hemmung von systemischen infektionen in menschen und wirbeltieren mit ballaststoffen

Info

Publication number: ATE315399T1
Authority: AT; Austria
Prior art keywords: inhibition; systemic infections; fiber; human; dietary fiber
Prior art date: 2000-09-28

Application number

AT01985674T

Other languages

English (en)

Inventor

Randal K Buddington

Loo Jan Van

Anne Frippiat

Original Assignee

Univ Mississippi

Tiense Suikerraffinaderij Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-09-28

Filing date

2001-09-27

Publication date

2006-02-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24693153&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE315399(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2001-09-27 Application filed by Univ Mississippi, Tiense Suikerraffinaderij Nv filed Critical Univ Mississippi

2006-02-15 Application granted granted Critical

2006-02-15 Publication of ATE315399T1 publication Critical patent/ATE315399T1/de

Links

241000251539 Vertebrata <Metazoa> Species 0.000 title abstract 3
208000015181 infectious disease Diseases 0.000 title abstract 3
230000005764 inhibitory process Effects 0.000 title abstract 3
230000009885 systemic effect Effects 0.000 title abstract 3
239000000835 fiber Substances 0.000 title 1
235000013325 dietary fiber Nutrition 0.000 abstract 5
239000000203 mixture Substances 0.000 abstract 4
229920001202 Inulin Polymers 0.000 abstract 2
244000052616 bacterial pathogen Species 0.000 abstract 2
JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 abstract 2
229940029339 inulin Drugs 0.000 abstract 2
230000002265 prevention Effects 0.000 abstract 2
241000723343 Cichorium Species 0.000 abstract 1
235000007542 Cichorium intybus Nutrition 0.000 abstract 1
229920002670 Fructan Polymers 0.000 abstract 1
235000013376 functional food Nutrition 0.000 abstract 1
238000004519 manufacturing process Methods 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
238000006116 polymerization reaction Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
- A23L33/22—Comminuted fibrous parts of plants, e.g. bagasse or pulp
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Food Science & Technology (AREA)
Molecular Biology (AREA)
Polymers & Plastics (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Nutrition Science (AREA)
Mycology (AREA)
Botany (AREA)
General Chemical & Material Sciences (AREA)
Oncology (AREA)
Chemical Kinetics & Catalysis (AREA)
Communicable Diseases (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Fodder In General (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)
Medicines Containing Plant Substances (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

AT01985674T 2000-09-28 2001-09-27 Hemmung von systemischen infektionen in menschen und wirbeltieren mit ballaststoffen ATE315399T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US09/671,106 US7431939B1 (en)	2000-09-28	2000-09-28	Inhibition of systemic infections in humans and vertebrates by dietary fibers

Publications (1)

Publication Number	Publication Date
ATE315399T1 true ATE315399T1 (de)	2006-02-15

Family

ID=24693153

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT01985674T ATE315399T1 (de)	2000-09-28	2001-09-27	Hemmung von systemischen infektionen in menschen und wirbeltieren mit ballaststoffen

Country Status (11)

Country	Link
US (1)	US7431939B1 (de)
EP (1)	EP1320375B1 (de)
JP (1)	JP4309650B2 (de)
CN (1)	CN1315482C (de)
AT (1)	ATE315399T1 (de)
CA (1)	CA2423783C (de)
DE (1)	DE60116662T2 (de)
DK (1)	DK1320375T3 (de)
ES (1)	ES2252317T3 (de)
NO (1)	NO331751B1 (de)
WO (1)	WO2002026242A2 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7431939B1 (en)	2000-09-28	2008-10-07	Mississippi State University	Inhibition of systemic infections in humans and vertebrates by dietary fibers
US20040001898A1 (en) *	2002-06-26	2004-01-01	Armand Malnoe	Compositions and methods for detoxification and cancer prevention
ZA200805905B (en)	2005-12-16	2009-10-28	Nutricia Nv	Use of soluble dietary fibres against muscle wasting
US20100316769A1 (en) *	2006-03-29	2010-12-16	Gail Czarnecki-Maulden	Dietary supplements containing probiotics
US20090061008A1 (en) *	2007-08-30	2009-03-05	Levy Mark M	Fiber/granule complex for treatment of the gi tract
SI2285387T1 (sl)	2008-06-13	2016-02-29	N.V. Nutricia	Prehrana za preprečevanje infekcij
CN103025307B (zh) *	2010-06-30	2017-03-29	雀巢产品技术援助有限公司	菊苣酸及衍生物用于调节皮肤色素沉着的用途
ES2738632T3 (es)	2012-02-16	2020-01-24	Akeso Biomedical Inc	Complejos de hierro para la reducción de la colonización del tracto gastrointestinal por Campylobacter
WO2013187755A1 (en)	2012-06-14	2013-12-19	N.V. Nutricia	Fermented infant formula with non digestible oligosaccharides
EP3079502A1 (de)	2013-11-04	2016-10-19	N.V. Nutricia	Fermentierte formel mit nichtverdaulichen oligosacchariden
CA2957790A1 (en) *	2014-08-13	2016-02-18	Akeso Biomedical, Inc.	Antimicrobial compounds and compositions, and uses thereof
RU2721257C2 (ru) *	2015-06-23	2020-05-18	Сосьете Де Продюи Нестле С.А.	Питательные композиции и детские смеси, содержащие олигофруктозу, для снижения нагрузки патогенных бактерий в кишечнике младенцев и детей младшего возраста
CN104872457A (zh) *	2015-06-23	2015-09-02	通威股份有限公司	一种提高罗非鱼抗链球菌能力的配合饲料
JP6637587B2 (ja) *	2015-08-04	2020-01-29	ズートツッカーアーゲー	副鼻腔炎に対するイヌリンの予防的使用
US10653658B2 (en)	2015-08-11	2020-05-19	Akeso Biomedical, Inc.	Biofilm inhibiting compositions enhancing weight gain in livestock
DK3334440T3 (en)	2015-08-11	2021-07-26	Akeso Biomedical Inc	Biofilm inhibiting compositions enhancing weight gain in livestock
CN105124248A (zh) *	2015-08-28	2015-12-09	通威股份有限公司	一种提高红罗非鱼抗病机能的配合饲料
EP3207933A1 (de) *	2016-02-17	2017-08-23	Proponent Biotech GmbH	Verwendungen von polyfructanen
BE1025705B1 (fr) *	2017-09-12	2019-06-18	Cosucra Groupe Warcoing Sa	Amélioration de la maladie et des conditions générales de la volaille et du bétail à l'aide d'une racine chicorée séchée
US10842811B2 (en) *	2018-02-28	2020-11-24	The Trustees Of Columbia University In The City Of New York	Inulin for preventing antibiotic resistant infection and pathogen colonization
CN120514728B (zh) *	2025-06-30	2026-03-10	湖南师范大学	菊糖在提高氨苄青霉素对耐药沙门氏菌作用效率中的应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3689071T2 (de) *	1985-10-31	1994-02-10	Univ Australian	Immunheilbehandlung.
US5032579A (en)	1987-10-13	1991-07-16	Coors Biotech, Inc.	Method for inhibiting the growth of salmonella
EP0483070B1 (de)	1990-10-24	1995-04-12	Novartis Nutrition AG	Vollwertnahrung aus hydrolysierten löslichen Faserstoffen
ES2060543B1 (es) *	1993-03-26	1995-04-01	Cia Gral Del Algarrobo De Espa	Fibra natural de algarroba y procedimiento para su obtencion.
EP0792889B1 (de)	1993-08-10	2000-12-27	Südzucker Aktiengesellschaft Mannheim/Ochsenfurt	Verwendung von Inulinderivaten
US6001878A (en)	1994-01-11	1999-12-14	Van Leeuwen; Paulus Aloisius Marie	Method of treating disorders of the animal or human body by administering amino acids
US6241983B1 (en) *	1994-10-28	2001-06-05	Metagenics, Inc.	Bacteria-and fiber-containing composition for human gastrointestinal health
US5531989A (en)	1994-10-28	1996-07-02	Metagenics, Inc.	Immunoglobulin and fiber-containing composition for human gastrointestinal health
DE69506095T2 (de) *	1995-08-04	1999-06-24	Naamloze Vennootschap Nutricia, Zoetermeer	Diätfasern enthaltende Nahrungszusammensetzung
EP0879600A1 (de) *	1997-05-20	1998-11-25	Tiense Suikerraffinaderij N.V. (Raffinerie Tirlemontoise S.A.)	Fruktan-haltige Zusammensetzung zur Vorbeugung und Behandlung von Dickdarmkrebs
ES2221014T3 (es)	1997-06-23	2004-12-16	Societe Des Produits Nestle S.A.	Composicion nutritiva que contiene fibras de guisante e inulina.
EP0904784A1 (de)	1997-09-22	1999-03-31	N.V. Nutricia	Probiotisches Ernährungspräparat
US6248375B1 (en) *	2000-03-14	2001-06-19	Abbott Laboratories	Diabetic nutritionals and method of using
US7431939B1 (en)	2000-09-28	2008-10-07	Mississippi State University	Inhibition of systemic infections in humans and vertebrates by dietary fibers
EP1428528A1 (de)	2002-09-27	2004-06-16	Tiense Suikerraffinaderij N.V.	Synergistische Zusammensetzungen aus Ballaststoffe und NSAID zur Behandlung von Krebs

2000
- 2000-09-28 US US09/671,106 patent/US7431939B1/en not_active Expired - Lifetime
2001
- 2001-09-27 CN CNB018165524A patent/CN1315482C/zh not_active Expired - Fee Related
- 2001-09-27 EP EP01985674A patent/EP1320375B1/de not_active Revoked
- 2001-09-27 AT AT01985674T patent/ATE315399T1/de not_active IP Right Cessation
- 2001-09-27 CA CA002423783A patent/CA2423783C/en not_active Expired - Fee Related
- 2001-09-27 JP JP2002530072A patent/JP4309650B2/ja not_active Expired - Fee Related
- 2001-09-27 DK DK01985674T patent/DK1320375T3/da active
- 2001-09-27 ES ES01985674T patent/ES2252317T3/es not_active Expired - Lifetime
- 2001-09-27 DE DE60116662T patent/DE60116662T2/de not_active Expired - Lifetime
- 2001-09-27 WO PCT/EP2001/011198 patent/WO2002026242A2/en not_active Ceased
2003
- 2003-03-19 NO NO20031259A patent/NO331751B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
CA2423783C (en)	2007-11-20
NO20031259D0 (no)	2003-03-19
DE60116662D1 (de)	2006-04-06
US7431939B1 (en)	2008-10-07
ES2252317T3 (es)	2006-05-16
JP2004509922A (ja)	2004-04-02
JP4309650B2 (ja)	2009-08-05
NO331751B1 (no)	2012-03-19
DE60116662T2 (de)	2006-11-09
EP1320375A2 (de)	2003-06-25
DK1320375T3 (da)	2006-05-22
WO2002026242A2 (en)	2002-04-04
CA2423783A1 (en)	2002-04-04
CN1466460A (zh)	2004-01-07
EP1320375B1 (de)	2006-01-11
CN1315482C (zh)	2007-05-16
NO20031259L (no)	2003-05-07
WO2002026242A3 (en)	2002-05-30

Legal Events

Date	Code	Title	Description
2006-07-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
ATE315399T1 (de)	2006-02-15	Hemmung von systemischen infektionen in menschen und wirbeltieren mit ballaststoffen
UA27848C2 (uk)	2000-10-16	Лікарська форма, що перорально вводиться, для лікування центральних станів дефіциту допаміну
BR0008059A (pt)	2002-03-26	Composições de valdecoxib
LU90987I2 (fr)	2003-02-25	Copaxone et ses dérivés pharmaceutiquement acceptables
BR9706897A (pt)	1999-08-31	Composições antifúngicas com biodisponibilidade aperfeiçoada.
KR920019342A (ko)	1992-11-19	골질환 치료제
IT1282353B1 (it)	1998-03-20	Composizione farmaceutica, in particolare liquida, per sommanistrazione orale di ondansetron e metodi per la sua produzione
TR200100629T2 (tr)	2001-07-23	Mide-bağırsak aktif maddeleri içeren mukozaya yapışan oral bileşimler
JP2004509922A5 (de)	2005-04-28
KR910009241A (ko)	1991-06-28	치근막 질환 치료용 서방성 조성물
CO5190674A1 (es)	2002-08-29	Tratamiento de desordenes neuroticos desordenes neuroticos
PT866791E (pt)	2002-05-31	Diaminopirimidinas formulacoes farmaceuticas que as contem e sua utilizacao antibacteriana
ATE153374T1 (de)	1997-06-15	Lps-produzierende bakterien, lipopolysiccharide und lps enthaltende arzneimittel und tierärztliche medikamente
KR890009400A (ko)	1989-08-01	다이클로닌 Hcl및 페놀을 함유하는 약제학적 조성물
BR9911962A (pt)	2001-03-27	Composição oral que apresenta eficiência antiplaca aumentada, e, processo para o tratamento e prevenção do acúmulo de placa bacteriana nos dentes.
KR910016327A (ko)	1991-11-05	호중구에 의한 엘라스타제 방출 저해제로서의 테니댑의 용도
KR960003718A (ko)	1996-02-23	말초신경병 및 중추신경변성병의 치료에 유용한 의약의 제조를 위한 이펜프로딜 및 그 부분입체이성질체의 이용
KR920011469A (ko)	1992-07-24	구강 조성물
BR0116373A (pt)	2004-07-06	Utilização de tienilciclo-hexilamina, produto, e, composições farmacêuticas
KR950700063A (ko)	1995-01-16	외상후 스트레스 치료제로서의 브로파로민(Brofaromine as an agent for treating post-traumatic stress)
Bugorkova	1999	Comparative characterization of the pathogenic action of Vibrio cholerae of group non-O 1, serovar O 139, and group O 1 on the APUD system of the intestine of suckling rabbits
KR930700100A (ko)	1993-03-13	수의학적 치료
KR960700053A (ko)	1996-01-19	방사선회복제로서 리루졸의 이용(application of riluzole as a radiorestorer)
DE60126504D1 (de)	2007-03-22	Verwendung von gegen candida wirksamen mitteln zur behandlung von störungen der oralen und intestinalen mucosa
KR960033451A (ko)	1996-10-22	나트륨 치환 트립토판을 포함하는 b형 간염 치료제